+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Blood Lancets Market by Type, and End User,: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031431
  • Report
  • March 2020
  • Region: Global
  • 165 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Abbott Laboratorie
  • Becton
  • Dickinson & Company
  • F.L. Medical SRL
  • Haemonetics Corporation
  • Improve Medical
The global blood lancets market was valued at $901.30 million in 2018 and is expected to reach $1,849.30 million by 2026, registering a CAGR of 9.4% from 2019 to 2026.



Blood lancet is a disposable or single use medical device primarily used for capillary blood sampling. These devices make small punctures in the skin to obtain blood samples that is further used for diagnosis of several diseases such as diabetes hyperlipidemia, blood cholesterol and dyslipidemia. These lancets are widely used by diabetic patients. Patients can easily use these devices at their homes and monitor their blood glucose level.

The major factors driving the growth of the global blood lancets market include significant increase in The prevalence of chronic diseases such as diabetes, hyperlipidemia, and dyslipidemia, and a rise in inclination toward home care diagnostics, are the major factors driving the blood lancets market growth. In addition, surge in use of disposable blood lancets for painless diagnosis of blood sugar level, hemoglobin, fat level, and other essential blood components, propels the market growth. Disposable lancet prevents the risk of blood transfusion and infection transmission, thereby contributing to the market growth. However, low awareness regarding homecare lancet in developing countries is anticipated to hamper the market growth. Moreover, promising regulatory scenario positively impacts the lancet market growth, thereby, creating lucrative opportunities in the near future.

The market is segmented on the basis of type, end-user, and region. By type, it is segmented into standard, safety blood lancets, and vacuum blood lancets. Based on end user, it is classified into hospitals & clinics, blood banks, homecare and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Type
  • Standard
  • Safety Blood Lancets
  • Vacuum Blood Lancets

By End-User
  • Hospitals &Clinics
  • Blood Banks
  • Homecare
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain

  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Becton, Dickinson & Company
  • Improve Medical
  • Terumo Corporation
  • Sarstedt AG & Co.
  • F.L. Medical SRL
  • Medtronic plc
  • Haemonetics Corporation
  • Shangdong Lianfa Medical
  • Nipro Medical Corporation
  • Abbott Laboratories
Frequently Asked Questions about the Global Blood Lancets Market

What is the estimated value of the Global Blood Lancets Market?

The Global Blood Lancets Market was estimated to be valued at $901.3 million in 2018.

What is the growth rate of the Global Blood Lancets Market?

The growth rate of the Global Blood Lancets Market is 9.4%, with an estimated value of $1849.3 million by 2026.

What is the forecasted size of the Global Blood Lancets Market?

The Global Blood Lancets Market is estimated to be worth $1849.3 million by 2026.

Who are the key companies in the Global Blood Lancets Market?

Key companies in the Global Blood Lancets Market include Becton, Dickinson & Company, Improve Medical, Terumo Corporation, Sarstedt AG & Co., F.L. Medical SRL, Medtronic plc, Haemonetics Corporation and Nipro Medical Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratorie
  • Becton
  • Dickinson & Company
  • F.L. Medical SRL
  • Haemonetics Corporation
  • Improve Medical

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Top player positioning
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of chronic diseases
3.4.1.2. Rise in reimbursement policies
3.4.2. Restraint
3.4.2.1. Lack of patient awareness regarding blood lancets
3.4.3. Opportunity
3.4.3.1. Opportunity in developing economies
CHAPTER 4: BLOOD LANCETS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast, by type
4.2. Standard
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Safety Blood Lancets
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Vacuum Blood Lancets
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: BLOOD LANCET MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast, by end user
5.2. Hospitals & Clinics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Blood Banks
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Homecare
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: BLOOD LANCET MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U. S.
6.2.2.1.1. U. S. market size and forecast, by type
6.2.2.1.2. U. S. market size and forecast, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by type
6.2.2.2.2. Canada market size and forecast, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico market size and forecast, by type
6.2.2.3.2. Mexico market size and forecast, by end user
6.2.3. Market size and forecast, by type
6.2.4. Market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by type
6.3.2.1.2. Germany market size and forecast, by end user
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by type
6.3.2.2.2. France market size and forecast, by end user
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by type
6.3.2.3.2. UK market size and forecast, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by type
6.3.2.4.2. Italy market size and forecast, by end user
6.3.2.5. Rest of Europe
6.3.2.5.1. Rest of Europe market size and forecast, by type
6.3.2.5.2. Rest of Europe market size and forecast, by end user
6.3.3. Market size and forecast, by type
6.3.4. Market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by type
6.4.2.1.2. Japan market size and forecast, by end user
6.4.2.2. China
6.4.2.2.1. China market size and forecast, by type
6.4.2.2.2. China market size and forecast, by end user
6.4.2.3. India
6.4.2.3.1. India market size and forecast, by type
6.4.2.3.2. India market size and forecast, by end user
6.4.2.4. Rest of Asia-Pacific
6.4.2.4.1. Rest of Asia-Pacific market size and forecast, by type
6.4.2.4.2. Rest of Asia-Pacific market size and forecast, by end user
6.4.3. Market size and forecast, by type
6.4.4. Market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil market size and forecast, by type
6.5.2.1.2. Brazil market size and forecast, by end user
6.5.2.2. South Africa
6.5.2.2.1. South Africa market size and forecast, by type
6.5.2.2.2. South Africa market size and forecast, by end user
6.5.2.3. Saudi Arabia
6.5.2.3.1. Saudi Arabia market size and forecast, by type
6.5.2.3.2. Saudi Arabia market size and forecast, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA market size and forecast, by type
6.5.2.4.2. Rest of LAMEA market size and forecast, by end user
6.5.3. Market size and forecast, by type
6.5.4. Market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories.
7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Product portfolio
7.1.4. Business performance
7.2. Becton Dickinson And Company
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. F L Medical S. R. L
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. Improve Medical (Guangzhou Improve Medical Instruments Co. , Ltd)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. Nipro Medical Corporation
7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Product portfolio
7.5.4. Business performance
7.6. Medtronic Plc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Owen Mumford
7.7.1. Company overview
7.7.2. company Snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. Sarstedt AG & CO.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. SteriLance Medical
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. Terumo corporation.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratorie
  • Becton
  • Dickinson & Company
  • F.L. Medical SRL
  • Haemonetics Corporation
  • Improve Medical
According to this report Titled, “Blood Lancets Market, by Type and End User: Global Opportunity Analysis and Industry Forecast, 2018-2026,' the global blood lancets market size is expected to reach $1,849.30million by 2026, registering a CAGR of 9.4% from 2019 to 2026, in terms of value.

Blood lancet is a medical device that is used to take blood samples. It procures through the skin and helps in obtaining blood sample for different tests such as blood glucose test, cholesterol test, identifying blood group among others. These lancets are widely used by diabetic patients to monitor their blood glucose level. Blood collected through the lancet can be used for disease diagnosis including cholesterol monitoring, diabetes, and various others. Blood lancets find their applications in home healthcare as well as in clinics or pathology labs to confirm individuals blood group.

Surge in The prevalence of diseases including diabetes, high cholesterol, and a rise in the use of lancets for home care diagnostics are the major factors fueling the blood lancets market growth. In addition, blood lancets offer non-invasive diagnosis of blood sugar level, hemoglobin, fat level, and other essential blood components. Disposable lancet combats infection transmission, further contributing to the blood lancets market growth. However, low awareness regarding homecare lancet in developing countries is anticipated to hamper the blood lancets market growth.

On the basis of type, the safety blood lancets segment accounted for 41% share in 2018, and is expected to exhibit a prominent growth rate in the near future, owing to its increased usage by the patients suffering with diabetes to self-monitor their blood sugar level.

Based on end user, the homecare segment dominated the blood lancets market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to significant increase in preference among patients towards homecare diagnosis of various chronic disease such as diabetes.

According to Onkar Sumant, Assistant Manager, Healthcare, “The growth of the global blood lancets market is due to the surge in The prevalence of diabetes across the globe. In addition, surge in preference toward homecare contributes to the market growth.

KEY FINDINGS OF THE STUDY
  • By type, the st andard segment accounted for the highest blood lancets market share of 55% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
  • By region, North America was the major shareholder and accounted for the highest share of 48% in 2018.
  • By end user, the homecare segment is expected to grow at a CAGR of 7.6% during the forecast period.
  • By region, the Asia-pacific segment is anticipated to grow at the fastest growth rate during the forecast period.

Comprehensive competitive analysis and profiles of major market players such as Becton, Dickinson & Company, Improve Medical, Terumo Corporation, Sarstedt AG & Co., F.L. Medical SRL, Medtronic plc, Haemonetics Corporation, ShangdongLianfa Medical, Nipro Medical Corporation and Abbott Laboratories. have been provided in this report.
Note: Product cover images may vary from those shown
  • Becton
  • Dickinson & Company
  • Improve Medical
  • Terumo Corporation
  • Sarstedt AG & Co.
  • F.L. Medical SRL
  • Medtronic plc
  • Haemonetics Corporation
  • ShangdongLianfa Medical
  • Nipro Medical Corporation
  • Abbott Laboratorie
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...